Skip to main content

ADVERTISEMENT

value-based care

Interview
02/13/2017
JCP Editors
Many health care providers and patient advocates have worked diligently to alter the perception of palliative care from something that occurs strictly at the end of life to an ongoing course of action for symptom...
Many health care providers and patient advocates have worked diligently to alter the perception of palliative care from something that occurs strictly at the end of life to an ongoing course of action for symptom...
Many...
02/13/2017
Journal of Clinical Pathways
Research in Review
02/13/2017
JCP Editors
The American College of Cardiology (ACC) has issued a decision pathway to for the selection, treatment, and follow-up care of patients with aortic stenosis who may be candidates for transcatheter aortic valve...
The American College of Cardiology (ACC) has issued a decision pathway to for the selection, treatment, and follow-up care of patients with aortic stenosis who may be candidates for transcatheter aortic valve...
The...
02/13/2017
Journal of Clinical Pathways
11/30/2016
JCP Editors
Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies, according to two studies presented at the 2016 ASH Annual Meeting and...
Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies, according to two studies presented at the 2016 ASH Annual Meeting and...
...
11/30/2016
Journal of Clinical Pathways
Research in Review
10/21/2016
JCP Editors
Most patients with metastatic urothelial cancer will become resistant to therapy. New research published in Nature Genetics showed that chemotherapy also shapes the genetic evolution of remaining urothelial cancer...
Most patients with metastatic urothelial cancer will become resistant to therapy. New research published in Nature Genetics showed that chemotherapy also shapes the genetic evolution of remaining urothelial cancer...
Most...
10/21/2016
Journal of Clinical Pathways
Research in Review
10/14/2016
JCP Editors
Cancer and its treatments lead to financial toxicity for patients, according to cancer specialists who reported the findings from using the Comprehensive Score for Financial Toxicity (COST) questionnaire in Cancer....
Cancer and its treatments lead to financial toxicity for patients, according to cancer specialists who reported the findings from using the Comprehensive Score for Financial Toxicity (COST) questionnaire in Cancer....
Cancer...
10/14/2016
Journal of Clinical Pathways
Research in Review
10/07/2016
JCP Editors
New findings presented by the Cancer Support Community suggest that a significant proportion of patients have difficulty conceptualizing value in terms of current cost-benefit models used by...
New findings presented by the Cancer Support Community suggest that a significant proportion of patients have difficulty conceptualizing value in terms of current cost-benefit models used by...
New...
10/07/2016
Journal of Clinical Pathways
Department
10/04/2016
JCP Editors
In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, treatment with hypofractionated radiation therapy offers similar health-related quality of life (HRQoL) outcomes in...
In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, treatment with hypofractionated radiation therapy offers similar health-related quality of life (HRQoL) outcomes in...
In the...
10/04/2016
Journal of Clinical Pathways
Research in Review
09/26/2016
JCP Editors
An analytic tool that allocates clinical care costs and quality measures to individual patient encounters may help to enhance the quality of care delivered by physicians, according to research published in JAMA. As...
An analytic tool that allocates clinical care costs and quality measures to individual patient encounters may help to enhance the quality of care delivered by physicians, according to research published in JAMA. As...
An...
09/26/2016
Journal of Clinical Pathways
Research in Review
09/09/2016
JCP Editors
Vinblastine monotherapy has similar outcomes and a more favorable toxicity profile compared with current therapies when used in patients with treatment naïve pediatric low-grade glioma (PLGG), according to a study...
Vinblastine monotherapy has similar outcomes and a more favorable toxicity profile compared with current therapies when used in patients with treatment naïve pediatric low-grade glioma (PLGG), according to a study...
...
09/09/2016
Journal of Clinical Pathways
Quiz
09/08/2016
JCP Editors
In a Viewpoint found in the most recent issue of Journal of Clinical Pathways, Dr Stephen McKenna contends that oncology patient-reported outcome measures (PROMs) are restrictive because they focus too much on a...
In a Viewpoint found in the most recent issue of Journal of Clinical Pathways, Dr Stephen McKenna contends that oncology patient-reported outcome measures (PROMs) are restrictive because they focus too much on a...
In a...
09/08/2016
Journal of Clinical Pathways